What does CUSIP N62509117 represent in this 13F holders report?

CUSIP N62509117 is the security identifier for NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 used to aggregate holder disclosures.

How many institutions held NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 in Q3 2022?

No institutional holders were reported for NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 in Q3 2022; review adjacent reporting periods for trend context.

999 (NAMSW)

CUSIP: N62509117

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / *W EXP 99/99/999
Total 13F shares: 0
Share change: -17,000
Total reported value: $0
Price per share: $23.00
Number of holders: 0
Value change: -$35,530
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP N62509117?
CUSIP N62509117 identifies NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP N62509117:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW)

Q3 2022 13F Holders as of 30 Sep 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 as of Q3 2022.